New approach todrug design yields highly promising bladder cancer drug candidate

(Trinity College Dublin) A new approach to molecular drug design has yielded a highly promising bladder cancer drug, which induced rapid shedding of tumour cells and resulted in a significant reduction in tumour size when used in clinical trials. These potent effects were seen in patients with non-muscle invasive bladder cancer (NMIBC) and the treatment was shown to be safe, as no drug-related side effects were observed.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news